세계의 문합기 시장 : 부문별 예측(2025-2030년)

The Anastomosis Devices Market was valued at USD 2.82 billion in 2023, expected to reach USD 3.04 billion in 2024, and is projected to grow at a CAGR of 7.96%, to USD 4.82 billion by 2030.

Anastomosis devices are critical in healthcare, specifically in surgeries involving the connection of blood vessels or tubular structures like the intestines. These devices include surgical staplers, suturing devices, and other advanced technologies for precise and reliable vascular anastomosis. The necessity for these devices stems from increasing incidences of cardiovascular and gastrointestinal diseases, as well as the growing elderly population requiring such interventions. Their application spans across various surgeries including gastrointestinal, cardiovascular, and organ transplants. In terms of end-use, hospitals, ambulatory surgical centers, and specialty clinics are significant sectors utilizing these devices. Market growth is largely driven by technological advancements, such as the development of minimally invasive and robotic-assisted surgeries, improving patient outcomes and reducing recovery time. Further, the rising importance of value-based healthcare has placed a spotlight on anastomosis devices for reducing complications and enhancing surgery success rates. Opportunities lie in emerging markets where healthcare infrastructures are improving and adopting state-of-the-art technologies. Companies can capitalize on this by expanding their footprint and collaborating with regional healthcare providers. Challenges that may impede growth include the high costs of advanced devices, stringent regulatory approvals, and potential complications associated with device use. Innovation is ripe in developing cost-effective, user-friendly devices with improved safety profiles. The use of bioresorbable materials, and AI-integrated devices for precision-operative protocols, are promising areas for research and development, addressing both cost and efficacy concerns. The market is dynamic, characterized by competitive pressures from new entrants offering disruptive innovations, but seasoned companies with robust R&D capabilities and strategic partnerships can leverage their experience to sustain growth. Strategic recommendations involve tapping into AI and data analytics to improve device performance and integrating comprehensive training programs for surgeons to maximize the effectiveness and safety of anastomosis devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anastomosis Devices Market

The Anastomosis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of off-pump, endoscopic, and minimally invasive surgeries
  • Proliferation of cardiovascular and gastrointestinal diseases
  • Increasing incidence of target diseases and the growing number of surgical procedures
• Market Restraints
  • High cost of devices and extensive clinical data requirements for product launch
• Market Opportunities
  • Refinement of automated distal anastomotic devices
  • Increasing R&D activities and soaring healthcare expenditure
• Market Challenges
  • Frequent product recalls and dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Anastomosis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anastomosis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anastomosis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anastomosis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anastomosis Devices Market

A detailed market share analysis in the Anastomosis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anastomosis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anastomosis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anastomosis Devices Market

A strategic analysis of the Anastomosis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anastomosis Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Cryolife, Inc., Getinge AB, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic Plc, MedVision Group, Meril Life Sciences Pvt. Ltd., Peters Surgical SASU, Purple Surgical, Seger Surgical Solutions Ltd, Synovis Micro Companies Alliance, Inc., and VITALITEC International Medical Technology GmbH.

Market Segmentation & Coverage

This research report categorizes the Anastomosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Surgical Sealants & Adhesives, Surgical Staplers, and Surgical Sutures. The Surgical Sealants & Adhesives is further studied across Natural or Biological Surgical Sealants & Adhesives and Synthetic and Semisynthetic Sealants & Adhesive. The Natural or Biological Surgical Sealants & Adhesives is further studied across Albumin-Based Sealants & Adhesives, Collagen-Based Sealants and Adhesives, and Fibrin-Based Sealants & Adhesives. The Synthetic and Semisynthetic Sealants & Adhesive is further studied across Cyanoacrylate-Based Sealants & Adhesives, Peg Hydrogel-Based Sealants & Adhesives, and Urethane-Based Sealants & Adhesives. The Surgical Staplers is further studied across Manual Surgical Staplers and Powered Surgical Staplers. The Surgical Sutures is further studied across Absorbable Sutures, Automated Suturing Devices, and Non-Absorbable Sutures. The Absorbable Sutures is further studied across Natural Sutures and Synthetic Sutures. The Synthetic Sutures is further studied across Poliglecaprone 25 Sutures, Polydioxanone Sutures, Polyglactin 910 Sutures, and Polyglycolic Acid Sutures. The Automated Suturing Devices is further studied across Disposable Automated Suturing Devices and Reusable Automated Suturing Devices. The Non-Absorbable Sutures is further studied across Nylon Sutures, Polypropylene Sutures, and Stainless Steel Sutures.
• Based on Application, market is studied across Cardiovascular & Thoracic Surgeries and Gastrointestinal Surgeries.
• Based on End User, market is studied across Ambulatory Surgery Centers & Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of off-pump, endoscopic, and minimally invasive surgeries
    • 5.1.1.2. Proliferation of cardiovascular and gastrointestinal diseases
    • 5.1.1.3. Increasing incidence of target diseases and the growing number of surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of devices and extensive clinical data requirements for product launch
  • 5.1.3. Opportunities
    • 5.1.3.1. Refinement of automated distal anastomotic devices
    • 5.1.3.2. Increasing R&D activities and soaring healthcare expenditure
  • 5.1.4. Challenges
    • 5.1.4.1. Frequent product recalls and dearth of trained professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anastomosis Devices Market, by Product

• 6.1. Introduction
• 6.2. Surgical Sealants & Adhesives
  • 6.2.1. Natural or Biological Surgical Sealants & Adhesives
    • 6.2.1.1. Albumin-Based Sealants & Adhesives
    • 6.2.1.2. Collagen-Based Sealants and Adhesives
    • 6.2.1.3. Fibrin-Based Sealants & Adhesives
  • 6.2.2. Synthetic and Semisynthetic Sealants & Adhesive
    • 6.2.2.1. Cyanoacrylate-Based Sealants & Adhesives
    • 6.2.2.2. Peg Hydrogel-Based Sealants & Adhesives
    • 6.2.2.3. Urethane-Based Sealants & Adhesives
• 6.3. Surgical Staplers
  • 6.3.1. Manual Surgical Staplers
  • 6.3.2. Powered Surgical Staplers
• 6.4. Surgical Sutures
  • 6.4.1. Absorbable Sutures
    • 6.4.1.1. Natural Sutures
    • 6.4.1.2. Synthetic Sutures
    • 6.4.1.2.1. Poliglecaprone 25 Sutures
    • 6.4.1.2.2. Polydioxanone Sutures
    • 6.4.1.2.3. Polyglactin 910 Sutures
    • 6.4.1.2.4. Polyglycolic Acid Sutures
  • 6.4.2. Automated Suturing Devices
    • 6.4.2.1. Disposable Automated Suturing Devices
    • 6.4.2.2. Reusable Automated Suturing Devices
  • 6.4.3. Non-Absorbable Sutures
    • 6.4.3.1. Nylon Sutures
    • 6.4.3.2. Polypropylene Sutures
    • 6.4.3.3. Stainless Steel Sutures

7. Anastomosis Devices Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular & Thoracic Surgeries
• 7.3. Gastrointestinal Surgeries

8. Anastomosis Devices Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers & Clinics
• 8.3. Hospitals

9. Americas Anastomosis Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Anastomosis Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Anastomosis Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Melsungen AG
• 2. Becton, Dickinson and Company
• 3. Cryolife, Inc.
• 4. Getinge AB
• 5. Intuitive Surgical, Inc.
• 6. Johnson & Johnson Services, Inc.
• 7. LivaNova PLC
• 8. Medtronic Plc
• 9. MedVision Group
• 10. Meril Life Sciences Pvt. Ltd.
• 11. Peters Surgical SASU
• 12. Purple Surgical
• 13. Seger Surgical Solutions Ltd
• 14. Synovis Micro Companies Alliance, Inc.
• 15. VITALITEC International Medical Technology GmbH